Parameter
| Biomarker | Urinary miR-106a | Full name | Urinary MicroRNA-106a | Molecular Type | RNA（miRNA） |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Diagnosis |
| Disease | Glomerulonephritis (GN) | Disease Subtypes | / | ||
| Organ | Kidney | Test Sample / Technology Platform | Urine（Liquid biopsy） | ||
| Pathobiological Mechanisms | The level of miR-106 a in urine has excellent sensitivity for the identification of IgAN and avoids the interference of markers related to renal scar formation. | ||||
| Clinical Availability Status | Research verification stage: High sensitivity, need to verify the role of screening | ||||
| Notes and Dynamics | Based on liquid biopsy technology, it is a potential marker for non-invasive diagnosis of IgAN, and its specificity needs to be further confirmed. | ||||